NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative, a research partnership between the European Commission and European pharmaceutical companies, will grant €156.3 million ($231.9 million) to researchers in its upcoming second funding call.

The IMI was created in 2007 to accelerate discovery and development of new drugs for cancer, inflammatory diseases, and infectious diseases by addressing important research bottlenecks in the process.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.